82.53
price up icon0.59%   0.6136
 
loading
Schlusskurs vom Vortag:
$81.92
Offen:
$81.33
24-Stunden-Volumen:
290.68K
Relative Volume:
0.28
Marktkapitalisierung:
$5.70B
Einnahmen:
$1.50B
Nettoeinkommen (Verlust:
$427.61M
KGV:
13.73
EPS:
6.01
Netto-Cashflow:
$423.98M
1W Leistung:
-8.89%
1M Leistung:
-14.06%
6M Leistung:
-14.75%
1J Leistung:
+45.71%
1-Tages-Spanne:
Value
$80.75
$83.82
1-Wochen-Bereich:
Value
$80.75
$93.27
52-Wochen-Spanne:
Value
$54.69
$126.89

Lantheus Holdings Inc Stock (LNTH) Company Profile

Name
Firmenname
Lantheus Holdings Inc
Name
Telefon
978 671-8001
Name
Adresse
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Name
Mitarbeiter
834
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
LNTH's Discussions on Twitter

Vergleichen Sie LNTH mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
LNTH
Lantheus Holdings Inc
82.50 5.70B 1.50B 427.61M 423.98M 6.01
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
173.12 78.63B 9.15B 2.43B 2.31B 5.32
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.8697 44.54B 14.26B 1.55B 0 0.3383
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.28 42.61B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.34 18.79B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
ITCI
Intra Cellular Therapies Inc
127.84 13.55B 612.78M -86.37M -62.91M -0.87

Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-18 Eingeleitet Goldman Buy
2024-09-03 Eingeleitet Redburn Atlantic Buy
2024-07-10 Bestätigt JMP Securities Mkt Outperform
2023-12-18 Herabstufung William Blair Outperform → Mkt Perform
2023-12-04 Eingeleitet TD Cowen Outperform
2023-09-29 Eingeleitet William Blair Outperform
2023-03-08 Eingeleitet JMP Securities Mkt Outperform
2022-11-30 Eingeleitet SVB Leerink Outperform
2022-10-13 Eingeleitet Mizuho Buy
2022-05-09 Eingeleitet B. Riley Securities Buy
2022-04-13 Eingeleitet Truist Buy
2021-02-01 Eingeleitet SVB Leerink Outperform
2020-06-29 Fortgesetzt Jefferies Buy
2019-08-16 Hochstufung CJS Securities Market Perform → Market Outperform
2017-11-02 Hochstufung Wells Fargo Market Perform → Outperform
2016-11-08 Bestätigt RBC Capital Mkts Outperform
2016-09-23 Fortgesetzt Credit Suisse Neutral
2016-02-24 Bestätigt RBC Capital Mkts Outperform
2015-12-11 Herabstufung Credit Suisse Outperform → Neutral
2015-09-30 Herabstufung Wells Fargo Outperform → Market Perform
2015-07-20 Eingeleitet Credit Suisse Outperform
2015-07-20 Eingeleitet Jefferies Buy
2015-07-20 Eingeleitet RBC Capital Mkts Outperform
2015-07-20 Eingeleitet Robert W. Baird Outperform
2015-07-20 Eingeleitet Wells Fargo Outperform
Alle ansehen

Lantheus Holdings Inc Aktie (LNTH) Neueste Nachrichten

pulisher
09:03 AM

B. Riley Adjusts Lantheus Holdings Price Target to $127 From $146, Maintains Buy Rating - Marketscreener.com

09:03 AM
pulisher
08:06 AM

Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time - The Manila Times

08:06 AM
pulisher
08:00 AM

Q4 Earnings Alert: Lantheus Set to Unveil Critical 2024 Performance Data - StockTitan

08:00 AM
pulisher
Feb 08, 2025

William Blair Issues Positive Estimate for Lantheus Earnings - Defense World

Feb 08, 2025
pulisher
Feb 07, 2025

Lantheus Holdings validates Fair Value model with 59% return since January 2024 - Investing.com India

Feb 07, 2025
pulisher
Feb 07, 2025

Trend Tracker for (LNTH) - Stock Traders Daily

Feb 07, 2025
pulisher
Feb 06, 2025

Why Lantheus Holdings Stock Got Thrashed on Tuesday - AOL

Feb 06, 2025
pulisher
Feb 05, 2025

Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting - The Bakersfield Californian

Feb 05, 2025
pulisher
Feb 05, 2025

Revolutionary Prostate Cancer Detection Breakthrough: Lantheus PYLARIFY Shows Success in Low PSA Patients - StockTitan

Feb 05, 2025
pulisher
Feb 05, 2025

Blue Trust Inc. Boosts Stake in Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World

Feb 05, 2025
pulisher
Feb 04, 2025

Here's Why You Should Add Lantheus (LNTH) to Your Portfolio - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

Lantheus Holdings, Inc. (LNTH): Among the Best Low Risk High Growth Stocks To Invest In Now - Insider Monkey

Feb 04, 2025
pulisher
Feb 04, 2025

Lantheus goes Evergreen in a $250m upfront deal - BioProcess Insider

Feb 04, 2025
pulisher
Feb 04, 2025

12 Best Low Risk High Growth Stocks to Invest In - Insider Monkey

Feb 04, 2025
pulisher
Feb 04, 2025

KBC Group NV Has $264,000 Position in Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World

Feb 04, 2025
pulisher
Feb 03, 2025

Janney Montgomery Scott LLC Acquires 5,753 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World

Feb 03, 2025
pulisher
Feb 03, 2025

Janney Montgomery Scott LLC Grows Position in Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat

Feb 03, 2025
pulisher
Feb 02, 2025

Lantheus Holdings, Inc. (NASDAQ:LNTH) Stock Position Increased by Swedbank AB - MarketBeat

Feb 02, 2025
pulisher
Feb 02, 2025

SkyOak Wealth LLC Buys 5,000 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat

Feb 02, 2025
pulisher
Jan 31, 2025

Lantheus (NASDAQ:LNTH) Releases FY 2024 Earnings Guidance - MarketBeat

Jan 31, 2025
pulisher
Jan 30, 2025

LNTHLantheus Holdings, Inc Latest Stock News & Market Updates - StockTitan

Jan 30, 2025
pulisher
Jan 30, 2025

Lantheus Appoints Dr. Morrow to Board of Directors - TipRanks

Jan 30, 2025
pulisher
Jan 30, 2025

Lantheus acquires radiopharma CDMO Evergreen for up to $1bn - MSN

Jan 30, 2025
pulisher
Jan 30, 2025

Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., to Board - citybiz

Jan 30, 2025
pulisher
Jan 30, 2025

Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member - The Manila Times

Jan 30, 2025
pulisher
Jan 30, 2025

Takeda's Oncology Chief Joins Lantheus Board: Major Win for Radiopharmaceutical Pipeline - StockTitan

Jan 30, 2025
pulisher
Jan 30, 2025

Lantheus Holdings, Inc. Enters Agreement to Acquire Evergreen TheragnosticsOn January 27, 2025, Lantheus Holdings, Inc. (NASDAQ: LNTH) announced that its subsidiary, Lantheus Medical Imaging, Inc., has entered into a definitive Agreement and Plan of - Defense World

Jan 30, 2025
pulisher
Jan 29, 2025

LNTH: Evergreen Acquisition Promotes Future Innovation - Research Tree

Jan 29, 2025
pulisher
Jan 29, 2025

Lantheus expands in neuro and oncology with LMI and Evergreen acquisitions - Medical Device Network

Jan 29, 2025
pulisher
Jan 29, 2025

Lantheus to acquire Evergreen Theragnostics for up to $1 billion - DOTmed

Jan 29, 2025
pulisher
Jan 29, 2025

Lantheus (LNTH) Stock Declines Amid Acquisition Announcement - GuruFocus.com

Jan 29, 2025
pulisher
Jan 29, 2025

Lantheus Holdings Inc. Announces Strategic Acquisition of Evergr - GuruFocus.com

Jan 29, 2025
pulisher
Jan 29, 2025

Lantheus to Acquire Evergreen Theragnostics for $250 Million - MSN

Jan 29, 2025
pulisher
Jan 28, 2025

Items Tagged with 'Life Molecular Imaging Ltd.' - BioWorld Online

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus lights up market with $1.025B Evergreen buy - BioWorld Online

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus to Acquire Evergreen Theragnostics to Expand Radiopharmaceutical Capabilities - HIT Consultant

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus to buy radiopharma CDMO Evergreen Theragnostics for $250M upfront - MM+M Online

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus to acquire Evergreen Theragnostics - MSN

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus to Acquire Evergreen Theragnostics in $1B Deal - USA Herald

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus (NASDAQ:LNTH) Trading Down 5.5%Should You Sell? - MarketBeat

Jan 28, 2025
pulisher
Jan 28, 2025

4 Firms Look To Build $1B Sale Of Evergreen Theragnostics - Law360

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus is on a buying spree. Its latest deal is worth up to $1B - The Business Journals

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus lights up market with up to $1B Evergreen buy - BioWorld Online

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus To Buy Evergreen Theragnostics For Over $1 Billion To Bolster Its Cancer Radiopharmaceutical Portfolio - Benzinga

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus Holdings to Acquire Evergreen Theragnostics - Contract Pharma

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment - GuruFocus.com

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus Holdings to Acquire Evergreen Theragnostics in All-Cash Transaction -January 28, 2025 at 06:52 am EST - Marketscreener.com

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader - PR Newswire

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus to Acquire Evergreen Theragnostics for Upfront - GlobeNewswire

Jan 28, 2025
pulisher
Jan 28, 2025

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive ... - The Bakersfield Californian

Jan 28, 2025
pulisher
Jan 28, 2025

Major Radiopharmaceutical Deal: Lantheus's $1B Game-Changing Move Into Cancer Treatment Manufacturing - StockTitan

Jan 28, 2025

Finanzdaten der Lantheus Holdings Inc-Aktie (LNTH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$11.32
price down icon 0.74%
$33.48
price up icon 4.82%
$114.94
price down icon 1.53%
$10.62
price up icon 0.19%
$127.80
price up icon 0.17%
Kapitalisierung:     |  Volumen (24h):